EUVIMEDEUVIMED entdecken
Crossref

Managing Medical Device Industry Innovation and Entrepreneurship in China

Zhang Kaiwen

Science Innovation · 24.12.2025 · 13 (6) · 190-193

DOI: 10.11648/j.si.20251306.19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Innovation, online erschienen am 24.12.2025. Verfasst von Zhang Kaiwen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focusing on mainland China, this paper builds an integrated framework for medical device innovation management and entrepreneurship aligned with NMPA/CMDE practice, DRG/DIP payment reforms, and volume-based procurement. We translate compliance requirements—such as device classification, clinical evaluation protocols, quality and risk management systems (including standards like YY/T 0316, YY/T 0664, and GB 9706), unique device identification (UDI), and post-market surveillance—into a comprehensive compliance-by-design operating model that emphasizes proactive risk mitigation and regulatory adherence. This framework incorporates stage-gate governance processes to manage development milestones, risk-adjusted valuation methods to assess financial viability, and portfolio optimization strategies to prioritize high-impact projects. Additionally, we align evidence generation with business objectives to facilitate hospital entry and tendering processes, ensuring that clinical data supports market access and reimbursement decisions. A detailed China-specific case study of a portable hemodynamic monitor illustrates how early engagement with regulatory bodies for scientific advice, real-world pilot studies, and results-based contracting can significantly enhance expected value projections and reduce time-to-access for patients. The paper concludes by exploring policy options to foster innovation, including the establishment of software as a medical device (SaMD) and artificial intelligence (AI) sandboxes for testing, broader acceptance of real-world evidence (RWE) in regulatory decisions, and health technology assessment (HTA) capacity building to support evidence-informed policymaking and sustainable healthcare innovation.

Zitieren

APA

Kaiwen, Z. (2025). Managing Medical Device Industry Innovation and Entrepreneurship in China. Science Innovation, 13(6), 190-193. https://doi.org/10.11648/j.si.20251306.19

Vancouver

Kaiwen Z. Managing Medical Device Industry Innovation and Entrepreneurship in China. Science Innovation. 2025;13(6):190-193. doi:10.11648/j.si.20251306.19

BibTeX
@article{Kaiwen2025,
  author = {Kaiwen, Zhang},
  title = {Managing Medical Device Industry Innovation and Entrepreneurship in China},
  journal = {Science Innovation},
  year = {2025},
  volume = {13},
  number = {6},
  pages = {190--193},
  doi = {10.11648/j.si.20251306.19}
}
Kostenlos starten →